Habib Georges Rizk

Habib Georges Rizk

Auto-generated profile, based on publicly available information

Habib Georges Rizk

Department of Otolaryngology – Head and Neck Surgery Medical University of South Carolina Charleston South Carolina USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2020 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
HRHabib G. Rizk
Habib G. Rizk
JLJoshua A. Lee
Joshua A. Lee
YLYuan F. Liu
Yuan F. Liu
LELauren Endriukaitis
Lauren Endriukaitis
JIJulianne L. Isaac
Julianne L. Isaac
WBWendy M. Bullington
Wendy M. Bullington

1 December 2014 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
SSShawn M. Stevens
Shawn M. Stevens
PLPaul R. Lambert
Paul R. Lambert
HRHabib Rizk
Habib Rizk
WMWesley R. McIlwain
Wesley R. McIlwain
SNShaun A. Nguyen
Shaun A. Nguyen
TMTed A. Meyer
Ted A. Meyer

1 August 2019 in Otology & Neurotology
Verified
Journal Article
Closed access
YLYuan F. Liu
Yuan F. Liu
TLTaylor D. Locklear
Taylor D. Locklear
JSJeffrey D. Sharon
Jeffrey D. Sharon
ELEmilie Lacroix
Emilie Lacroix
SNShaun A. Nguyen
Shaun A. Nguyen
HRHabib G. Rizk
Habib G. Rizk
Objective: Currently available patient reported outcomes questionnaires for dizzy patients give limited insight into the cognitive dysfunction patients often report. Using the newly developed English version of the neuropsychological vertigo inventory (NVI), we aimed to quantify the cognitive impairment of dizzy patients. Study Design: Prospective cohort study. Setting: Tertiary neurotology clinic. Patients: Adults with vestibular diagnoses seen between June 2018 and October 2018. Patients with neurologic disorders affecting cognition were excluded. Interventions: None. Main Outcome Measure: NVI score. Secondary measures: dizziness handicap inventory (DHI) score, cognitive failure questionnaire (CFQ) score, 20-item short form health survey scores (SF20). Results: Of 67 subjects, 13 had BPPV, 11 had Menière's disease (MD), and 20 had vestibular migraine (VM). VM patients were significantly younger (43.5 versus 61.1 yrs, p = 0.016), and had significantly higher NVI (67.5 versus 51.0, p = 0.040) scores than BPPV patients. MD patients had significantly higher CFQ scores (44.8 versus 23.4, p = 0.015) than BPPV patients. NVI scores were similar between MD (67.3) and VM (67.5) patients (p = 1.000). DHI scores were similar for all patients (p = 0.102). NVI scores were highly correlated to CFQ scores (r = 0.864, p < 0.001). Conclusions: VM patients have levels of cognitive dysfunction similar to MD patients, but greater than BPPV patients. A lack of difference in DHI scores among these patients reflects its limitation in assessing the cognitive domain.

1 September 2011 in European Annals of Otorhinolaryngology, Head and Neck Diseases
Verified
Journal Article
Closed access
HRH. Rizk
H. Rizk
SRS. Rassi
S. Rassi

1 December 2022 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
SJSeth S. Jeong
Seth S. Jeong
KSKit N. Simpson
Kit N. Simpson
JJJada M. Johnson
Jada M. Johnson
HRHabib G. Rizk
Habib G. Rizk
Dizziness is a term used to describe a range of sensations that leads to an impairment of spatial orientation or balance. Patients most commonly use descriptors such as feeling faint, woozy, weak, or unsteady. Vertigo, in particular, is an illusion of movement that is often related to problems with the inner ear and accounts for approximately 25% of patients with dizziness.1,2 The 3 most common episodic vestibular disorders that cause vertigo are benign paroxysmal positional vertigo (BPPV), vestibular migraine (VM), and Ménière disease (MD).3,4 Benign paroxysmal positional vertigo is present in approximately 20% to 30% of diagnoses in dizziness clinics.5-7 Ménière disease is present in approximately 13% of patients referred to dizziness clinics.7 Vestibular migraine could be present in up to 23.4% of patients with dizziness.8 Altogether BPPV, VM, and MD seem to account for about 50% of patients presenting to the clinic for dizziness. These disease processes are known to severely affect essential activities of daily living, quality of life, work, and social interactions.9-11 All of these factors can lead to considerable direct and indirect costs for the individuals experiencing it.

7 April 2020 in Otology & Neurotology
Verified
Journal Article
Closed access
HRHabib G. Rizk
Habib G. Rizk
YLYuan F. Liu
Yuan F. Liu
CSChristine C. Strange
Christine C. Strange
CACortney H. Van Ausdal
Cortney H. Van Ausdal
RERebecca C. English
Rebecca C. English
TMTed A. Meyer
Ted A. Meyer
Objective: To explore the usefulness of vestibular evoked myogenic potentials (VEMPs) in the diagnosis of Menière's disease (MD) and vestibular migraine (VM). Study Design: Retrospective cohort. Setting: Multidisciplinary neurotology clinic. Patients: Definite MD and definite VM patients between January, 2015 and May, 2017, as well as healthy volunteers. Interventions: Cervical and ocular VEMP (cVEMP and oVEMP) testing. Main Outcome Measures: VEMP response, amplitude, and latency. Results: Twenty five definite MD, 34 definite VM, and 13 control subjects were analyzed. MD affected ears had significantly lower cVEMP (p = 0.007) and oVEMP (p < 0.001) amplitudes than control ears. VM ears had significantly lower oVEMP (p = 0.001), but not cVEMP (p = 0.198) amplitudes than control ears. MD affected ears, but not VM ears, had significantly more absent cVEMP (25.9% versus 0%, p = 0.005) and oVEMP responses (40.7% versus 0%, p < 0.001) than control ears. oVEMP latency was significantly shorter for both MD affected (p < 0.001) and VM ears (p < 0.001) than control ears. Sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were calculated using a neurotology clinic MD prevalence of 7.9% in dizzy patients. A present cVEMP or oVEMP both have more than 93% chance of ruling MD out in the tested ear, while a cVEMP amplitude more than 54.9 μV or oVEMP amplitude more than 5.1 μV both have more than 94% of ruling out MD in the tested ear. Conclusions: Despite some overlap in VEMP results between MD and VM, when the diagnosis is uncertain between the two disorders due to symptomatic overlap and nonspecific audiometric data, VEMPs can be helpful in guiding treatment toward one disease entity or the other until more evidence points to a definitive diagnosis.